Navigation Links
Anti-Sense Drugs and Nanotechnology Offer New Hope In Cancer Fight

Scientists have developed a new class of drugs called antisense drugs, which can block the genes associated with production of harmful proteins//. Until now, it has been difficult for scientists to find a way by which special cancer drugs can be prevented from breaking down before they reach the target genes.

But now, this problem can be overcome by combining the drugs with small gold particles. This novel finding has been the result of the sustained efforts of researchers at the Northwestern University.

Cancer and a spectrum of other disorders arise as a result of a subtle alteration in the genetic material (mutation). Mutation in a gene results in excessive production of copies of certain proteins that can pave way for cancer and other disorders.

The conventional drugs target these excess or harmful proteins while the new generation drugs (antisense drugs) target the genetic material itself, inhibiting production of the harmful protein. Although this new form of therapy is in a preliminary stage, it promises to be more effective than all forms of existing drug treatment.

When extremely small gold particles (a fraction of the width of the human hair) are attached to multiple strands of antisense DNA, it resulted in a stable delivery of these drugs to the required site of action. Less toxicity and ready absorption of these drugs into cells offer a unique advantage of this particular form of therapy.

‘In the future, this exciting new class of antisense material could be used for the treatment of cancer and other diseases that have a genetic basis. Once inside cells, the DNA modified nanoparticles act as sponges that bind to their targets and prevent them from being converted to proteins,’ said Chad Mirkin, lead author of the study.

‘Powerful new cancer drugs will only live up to their potential if they can be efficiently delivered to cancer cells. This study accomplishes this by combining two exciting and relatively new technologies - antisense drugs and nanotechnology. In upcoming years, we are likely to see nanotechnology play a greater role in detecting and treating cancers,’ said Ed Yong of the Cancer Research, UK.

Source: Eurekaler
'"/>




Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
3. Nasal Spray Could Take Drugs Direct to Brain.
4. Emphasis to ban Drugs ads by Doctors
5. Osteoporosis Drugs: right time to take-off
6. Drugs disrupt formation of blood vessels
7. Drugs to stop burgeon of HIV
8. Misleading Advertisements for Prescription Drugs
9. Drugs For Anthrax May Interfere With Oral Contraceptives
10. Over-The-Counter Drugs May Prevent Alzheimers
11. Steps To Improve Quality Of Plant-Based Drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
Breaking Medicine Technology: